GlassScriptPhysician profile
Krista Budanov
NPI 1861915357
$7,776.74
in general payments reported to CMS, 2019-2025
37 companies · $1,880 in 2025
The $1,880 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,006 · 2022: $1,532 · 2023: $1,957 · 2024: $1,402 · 2025: $1,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,238.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,804.57 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $951.20 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $928.29 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $575.04 | 2021-2025 | Evenity, Repatha, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $517.17 | 2022-2025 | |
| Glaxosmithkline, LLC. | $361.57 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Corcept Therapeutics | $355.76 | 2022-2024 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.60 | 2021-2025 | Xifaxan |
| Astellas Pharma US INC | $216.66 | 2024-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $203.27 | 2022-2023 | |
| Exact Sciences Corporation | $166.43 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $162.81 | 2022-2025 | |
| Esperion Therapeutics, INC. | $113.52 | 2021-2025 | Nexletol |
| Vanda Pharmaceuticals INC. | $112.67 | 2025 | Fanapt |
| Lilly USA, LLC | $111.67 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Budanov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.